Do I understand the distinction between dietary supplements and prescription medications
The practical reality is that many purchasers use these compounds for personal use rather than formal research
Eli Lilly announced positive Phase 3 results for retatrutide, a first-in-class triple agonist targeting GLP-1, GIP, and glucagon receptors
Movement, Your Way Whether its walking, stretching or dancing in your kitchen, the app lets you track activity in a way that suits you and syncs with the main fitness wearables like Garmin, Apple and Fitbit.
By partnering with us, youll gain access to cutting-edge protocols, ongoing education, and a supportive community of like-minded professionals
In this phase 2 trial in participants with obesity and MASLD, once-weekly treatment with the GIP/GLP-1/GCG triple agonist retatrutide resulted in substantial reductions in liver fat, body weight, ASAT and VAT, which were associated with improvements in insulin sensitivity, serum lipids, K-18 and pro-C3